CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to RHHBY

Intravitreal Ranibizumab 0.5 mg Injection

Phase 3
Roche Holding AG (RHHBY)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q3 '27
RHHBYPhase 3

Intravitreal Ranibizumab 0.5 mg Injection Phase 3 Est. Readout

Intravitreal Ranibizumab 0.5 mg Injection
Q3 2027~Q
CT.gov
00%
Competitive Landscape
Drug Information

Target Indication

Diabetic Macular Edema

Clinical Trial

NCT04108156

Last updated: 2/26/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.